Business Context and Reporting Period
Company: Landec Corporation (Note: Input metadata referenced "LIFECORE BIOMEDICAL, INC.", but the filing text is for Landec Corporation).
Filing Type: Form 10-Q (Quarterly Report).
Period: Fiscal quarter ended August 30, 2009.
Business Overview: Landec designs, develops, and sells temperature-activated polymer products. Operations are divided into three segments: Food Products Technology (Apio, Inc., selling fresh-cut produce and packaging), Commodity Trading (buy/sell of whole produce), and Technology Licensing (Intellicoat seed coatings and Intelimer polymers).
Key Financial Metrics
| Metric | Q1 2010 (Ended Aug 30, 2009) | Q1 2009 (Ended Aug 31, 2008) |
|---|---|---|
| Total Revenues | $60.9 million | $71.8 million |
| Gross Profit | $8.9 million | $10.1 million |
| Gross Margin | 14.6% | 14.1% |
| Operating Income | $3.4 million | $4.6 million |
| Net Income (Common Stockholders) | $2.2 million | $2.8 million |
| Diluted EPS | $0.08 | $0.11 |
| Cash & Equivalents (End of Period) | $4.0 million | $45.7 million |
| Marketable Securities | $65.5 million | $22.5 million |
| Total Assets | $163.7 million | $153.5 million |
| Total Liabilities | $33.6 million | $26.3 million |
| Operating Cash Flow | $4.3 million | $2.2 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 15% to $60.9 million. This was driven by a 33% drop in Commodity Trading revenues (due to reduced export volumes and exiting domestic Wal-Mart business) and a 4% decline in Apio Value-Added revenues (partially due to a 13-week vs. 14-week period comparison).
- Liquidity Shift: Cash and cash equivalents dropped significantly from $43.5 million to $4.0 million. This decrease was primarily due to a net purchase of $43.0 million in marketable securities and $1.3 million in capital expenditures for facility expansion.
- Working Capital: Accounts receivable increased by $4.0 million, and inventories increased by $2.6 million due to seasonal buildup. Accounts payable increased by $7.2 million due to timing of payments.
- Profitability: Net income applicable to common stockholders decreased 23% to $2.2 million, reflecting lower revenues and a slight decrease in the effective tax rate (37% vs 40% prior year).
Guidance, Outlook, and Risks
- Outlook: Management believes existing cash, cash equivalents, and marketable securities are sufficient to finance operations for at least the next twelve months. No specific numerical guidance was provided in this filing.
- Strategic Focus: Continued expansion of Apio's value-added processing facility and automation. Focus on commercializing Intellicoat seed coatings with Monsanto and Intelimer polymers for industrial and medical applications.
- Risks:
- Economic Conditions: Global economic slowdown and volatility may reduce demand and impact customer creditworthiness.
- Customer Concentration: Top five customers accounted for 50% of revenues; Costco Wholesale Corp. alone accounted for 19%.
- Seasonality & Weather: Operations are subject to weather conditions affecting crop yields and commodity prices.
- Regulatory: Subject to FDA, USDA, and environmental regulations; potential for product liability claims.
- Unusual Items: The filing notes a significant shift in investment strategy, moving cash into marketable securities (municipal bonds and CDs) totaling $65.5 million.
Investor Verification Checklist
- Cash Deployment: Verify the rationale and expected yield for the $43 million net purchase of marketable securities given the drop in liquid cash.
- Customer Concentration: Assess the risk exposure related to Costco (19% of revenue) and the top five customers (50% of revenue).
- Commodity Trading Exit: Confirm the status of the planned exit from the domestic buy/sell business with Wal-Mart and its long-term impact on revenue stability.
- Inventory Levels: Review the $2.6 million increase in inventory to ensure it aligns with seasonal demand and does not indicate obsolescence risks.
- Goodwill Valuation: Monitor the $27.4 million goodwill balance for potential impairment triggers given the economic volatility and revenue declines.